{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:40:06Z","timestamp":1783996806959,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43TW010526"],"award-info":[{"award-number":["D43TW010526"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Malar."],"abstract":"<jats:p>Malaria remains a global health crisis, causing an estimated 263 million cases and 597,000 deaths in 2023. Current measures\u2014including insecticide-treated nets, ACTs, and the RTS,S vaccine\u2014have stalled in reducing mortality, highlighting the need for novel strategies. While studies IgG and IgM have dominated malaria immunology research, recent data reveal a broader role for Immunoglobulin A (IgA). Evidence suggests that IgA can block parasite entry, activate complement, and modulate inflammation, although its protective efficacy has yet to be established. This review synthesizes the emerging literature on sporozoite- and merozoite-specific IgA responses, examines how IgA arises in a \u201cnon-mucosal\u201d infection like malaria, and explores vaccine platforms-oral, nasal, or prime-boost-that might harness IgA alongside IgG. We also identify critical gaps in correlating IgA levels with clinical immunity, emphasizing the need for specialized animal models and longitudinal human cohorts. Ultimately, leveraging IgA-driven mucosal immunity could significantly reinforce existing malaria interventions by preventing parasite establishment at mucosal or skin interfaces. By uniting mucosal and systemic immunity, research on IgA-based vaccines promises a next-generation approach to reducing malaria transmission, thereby creating a path towards global eradication.<\/jats:p>","DOI":"10.3389\/fmala.2025.1557371","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T09:08:08Z","timestamp":1750842488000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting mucosal immunity in malaria control: the underexplored role of IgA"],"prefix":"10.3389","volume":"3","author":[{"given":"Haruna","family":"Muwonge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Ssewanyana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adoke","family":"Yeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Byakika-Kibwika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1128\/iai.00640-09","article-title":"Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission in both passive and active vaccination regimens in a rodent model of malaria infection","volume":"77","author":"Arakawa","year":"2009","journal-title":"Infect. Immun."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-04020-6","article-title":"Naturally acquired antibody response to a plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and pfs48\/45) in individuals living in Brazilian malaria-endemic areas","volume":"21","author":"Baptista","year":"2022","journal-title":"Malaria J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41541-021-00363-y","article-title":"Immunoprofiles associated with controlled human malaria infection and naturally acquired immunity identify a shared IgA pre-erythrocytic immunoproteome","volume":"6","author":"Berry","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.0105-2896.2005.00299.x","article-title":"Bronchus- and nasal-associated lymphoid tissues","volume":"206","author":"Bienenstock","year":"2005","journal-title":"Immunol. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4049\/jimmunol.1601775","article-title":"Inducing mucosal igA: A challenge for vaccine adjuvants and delivery systems","volume":"199","author":"Boyaka","year":"2017","journal-title":"J. Immunol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00185","article-title":"Multi-faceted functions of secretory igA at mucosal surfaces","volume":"4","author":"Corth\u00e9sy","year":"2013","journal-title":"Front. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1007\/s11033-019-04822-7","article-title":"Erythrocyte binding ligand region VI specific IgA confers tissue protection in malaria infection","volume":"46","author":"Deore","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.974854","article-title":"Advances in IgA glycosylation and its correlation with diseases","volume":"10","author":"Ding","year":"2022","journal-title":"Front. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1093\/ndt\/13.8.1984","article-title":"Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy","volume":"13","author":"Endo","year":"1998","journal-title":"Nephrol. Dial Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1073\/pnas.061412598","article-title":"Peyer\u2019s patches are required for oral tolerance to proteins","volume":"98","author":"Fujihashi","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1056\/nejmoa1606701","article-title":"Mapping plasmodium falciparum mortality in africa between 1990 and 2015","volume":"375","author":"Gething","year":"2016","journal-title":"New Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1053\/ajkd.2001.28611","article-title":"Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis","volume":"38","author":"Hisano","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200901","article-title":"Plasmodium falciparum-specific IgM B cells dominate in children, expand with malaria, and produce functional IgM","volume":"218","author":"Hopp","year":"2021","journal-title":"J. Exp. Med."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2573-1","article-title":"Impact evaluation of malaria control interventions on morbidity and all-cause child mortality in Mali 2000\u20132012","volume":"17","author":"Kayentao","year":"2018","journal-title":"Malaria J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12916-018-1054-2","article-title":"Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children","volume":"16","author":"Kurtovic","year":"2018","journal-title":"BMC Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1016\/j.vaccine.2014.08.089","article-title":"The mucosal immune system for vaccine development","volume":"32","author":"Lamichhane","year":"2014","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0554-1","article-title":"A cohort study of the effectiveness of insecticide-treated bed nets to prevent malaria in an area of moderate pyrethroid resistance, Malawi","volume":"14","author":"Lindblade","year":"2015","journal-title":"Malaria J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"Macpherson","year":"2008","journal-title":"Mucosal Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1681\/asn.2014101000","article-title":"Current understanding of the role of complement in igA nephropathy","volume":"26","author":"Maillard","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3201\/eid1302.060631","article-title":"Reduced efficacy of insecticide-treated nets and indoor residual spraying for malaria control in pyrethroid resistance area, Benin","volume":"13","author":"N\u2019Guessan","year":"2007","journal-title":"Emerging Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/infdis\/jiad115","article-title":"Accumulation of neutrophil phagocytic antibody features tracks with naturally acquired immunity against malaria in children","volume":"228","author":"Nziza","year":"2023","journal-title":"J. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2119\/2007-00093.Owuor","article-title":"Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia","volume":"14","author":"Owuor","year":"2008","journal-title":"Mol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1365-3024.2009.01101.x","article-title":"Fc-receptors and immunity to malaria: from models to vaccines","volume":"31","author":"Pleass","year":"2009","journal-title":"Parasite Immunol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taab046","article-title":"Trends of the global, regional and national incidence of malaria in 204 countries from 1990 to 2019 and implications for malaria prevention","volume":"28","author":"Qiao","year":"2021","journal-title":"J. Travel Med."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.683404","article-title":"Beyond binding: the outcomes of antibody-dependent complement activation in human malaria","volume":"12","author":"Rathnayake","year":"2021","journal-title":"Front. Immunol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.869028","article-title":"Antibody dynamics in children with first or repeat Plasmodium falciparum infections","volume":"9","author":"Rogier","year":"2022","journal-title":"Front. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41541-023-00701-2","article-title":"Multifunctional IgG\/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine","volume":"8","author":"Rosenkranz","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-11-77","article-title":"The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP119)","volume":"11","author":"Shi","year":"2011","journal-title":"BMC Biotechnol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.vaccine.2020.12.038","article-title":"RTS,S\/AS01E malaria vaccine induces igA responses against CSP and vaccine-unrelated antigens in african children in the phase 3 trial","volume":"39","author":"Suau","year":"2021","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg2344","article-title":"Functional human igA targets a conserved site on malaria sporozoites","volume":"13","author":"Tan","year":"2021","journal-title":"Sci. Trans. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/v2010283","article-title":"The development of an AIDS mucosal vaccine","volume":"2","author":"Tang","year":"2010","journal-title":"Viruses"},{"key":"B32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/s0140-6736(19)31097-9","article-title":"Mapping the global prevalence, incidence, and mortality of plasmodium falciparum 2000\u201317: A spatial and temporal modelling study","volume":"394","author":"Weiss","year":"2019","journal-title":"Lancet"},{"key":"B33","article-title":"Malaria (Press release)","year":"2024"}],"container-title":["Frontiers in Malaria"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmala.2025.1557371\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T09:08:09Z","timestamp":1750842489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmala.2025.1557371\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":33,"alternative-id":["10.3389\/fmala.2025.1557371"],"URL":"https:\/\/doi.org\/10.3389\/fmala.2025.1557371","relation":{},"ISSN":["2813-7396"],"issn-type":[{"value":"2813-7396","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"1557371"}}